Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus to present data on ‘ZYDPLA1’ at ENDO conference

>>

Cadila Healthcare fixes Book Closure for Dividend & AGM

>>

Cadila Healthcare spurts on commencing Phase 3 trials of Lipaglyn

>>

Zydus commences Phase 3 trials of Lipaglyn in patients suffering from Lipodystrophy

>>

Cadila Healthcare board recommends Dividend

>>

Cadila Healthcare informs about appointment of Director

>>

Cadila Healthcare declines on reporting 9% fall in Q4 consolidated net profit

>>

Cadila Healthcare reports 9% fall in Q4 consolidated net profit

>>

Cadila Healthcare gains on entering into settlement agreement with Depomed on Gralise

>>

Cadila Healthcare enters into settlement agreement with Depomed on Gralise

<< < 158 159 160 ...168 > >>